Icosapent ethyl for reducing the risk of cardiovascular events

MLA

Steve Chaplin. “Icosapent Ethyl for Reducing the Risk of Cardiovascular Events.” Prescriber, vol. 34, Feb. 2023, pp. 30–31. EBSCOhost, https://doi.org/10.1002/psb.2045.

APA

Steve Chaplin. (2023). Icosapent ethyl for reducing the risk of cardiovascular events. Prescriber, 34, 30–31. https://doi.org/10.1002/psb.2045

Chicago

Steve Chaplin. 2023. “Icosapent Ethyl for Reducing the Risk of Cardiovascular Events.” Prescriber 34 (February): 30–31. doi:10.1002/psb.2045.